News | August 30, 2021
Granules India receives approval from Health Canada for arthritis drug
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
The collaboration will support Canada with direct access to rapid pandemic response capabilities
Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
At the center of the announcement are two late-breaking studies that could reshape treatment approaches for patients with high cholesterol and a complex form of heart failure
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC
The decision marks a pivotal moment for the Massachusetts-based biotech giant
The order will cover the manufacturing of bulk vaccine in 2026
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
Subscribe To Our Newsletter & Stay Updated
